3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
39
Leukemia
16
Congenital Abnormalities
10
Leukemia, Monocytic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Myelodysplastic Syndromes
5
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Eosinophilic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Promyelocytic, Acute
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Basophilic, Acute
2
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Interventions
Imatinib Mesylate
6
Cytarabine
5
ponatinib
4
nilotinib
4
venetoclax
3
fludarabine phosphate
3
Mycophenolic Acid
3
thymoglobulin
2
fludarabine
2
enasidenib
2
Methotrexate
2
Lenalidomide
2
Cyclosporine
2
Cyclophosphamide
2
Azacitidine
2
Antilymphocyte Serum
2
quizartinib
1
methanesulfonic acid
1
glasdegib
1
etoposide phosphate
1
daratumumab
1
bosutinib
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Standard of Care
1
RFT5-SMPT-dgA immunotoxin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid
×
Idarubicin
×
Clear all
No trials found.